BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 11237521)

  • 21. Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.
    Leslie NR; Bennett D; Gray A; Pass I; Hoang-Xuan K; Downes CP
    Biochem J; 2001 Jul; 357(Pt 2):427-35. PubMed ID: 11439092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The biology and clinical relevance of the PTEN tumor suppressor pathway.
    Sansal I; Sellers WR
    J Clin Oncol; 2004 Jul; 22(14):2954-63. PubMed ID: 15254063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors.
    Di Vizio D; Cito L; Boccia A; Chieffi P; Insabato L; Pettinato G; Motti ML; Schepis F; D'Amico W; Fabiani F; Tavernise B; Venuta S; Fusco A; Viglietto G
    Oncogene; 2005 Mar; 24(11):1882-94. PubMed ID: 15674339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel loss-of-function mutation (N48K) in the PTEN gene in a Spanish patient with Cowden disease.
    Vega A; Torres J; Torres M; Cameselle-Teijeiro J; Macia M; Carracedo A; Pulido R
    J Invest Dermatol; 2003 Dec; 121(6):1356-9. PubMed ID: 14675182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological role of phosphatase PTEN in cancer and tissue injury healing.
    Tsugawa K; Jones MK; Sugimachi K; Sarfeh IJ; Tarnawski AS
    Front Biosci; 2002 May; 7():e245-51. PubMed ID: 11991859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline mutations in PTEN are present in Bannayan-Zonana syndrome.
    Marsh DJ; Dahia PL; Zheng Z; Liaw D; Parsons R; Gorlin RJ; Eng C
    Nat Genet; 1997 Aug; 16(4):333-4. PubMed ID: 9241266
    [No Abstract]   [Full Text] [Related]  

  • 27. Pten, a protean tumor suppressor.
    Mutter GL
    Am J Pathol; 2001 Jun; 158(6):1895-8. PubMed ID: 11395362
    [No Abstract]   [Full Text] [Related]  

  • 28. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.
    Cantley LC; Neel BG
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4240-5. PubMed ID: 10200246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells.
    Taylor V; Wong M; Brandts C; Reilly L; Dean NM; Cowsert LM; Moodie S; Stokoe D
    Mol Cell Biol; 2000 Sep; 20(18):6860-71. PubMed ID: 10958682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling.
    Vazquez F; Sellers WR
    Biochim Biophys Acta; 2000 Feb; 1470(1):M21-35. PubMed ID: 10656987
    [No Abstract]   [Full Text] [Related]  

  • 31. SHIP-2 and PTEN are expressed and active in vascular smooth muscle cell nuclei, but only SHIP-2 is associated with nuclear speckles.
    Déléris P; Bacqueville D; Gayral S; Carrez L; Salles JP; Perret B; Breton-Douillon M
    J Biol Chem; 2003 Oct; 278(40):38884-91. PubMed ID: 12847108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PTEN and Other PtdIns(3,4,5)P
    Csolle MP; Ooms LM; Papa A; Mitchell CA
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis.
    Lynch ED; Ostermeyer EA; Lee MK; Arena JF; Ji H; Dann J; Swisshelm K; Suchard D; MacLeod PM; Kvinnsland S; Gjertsen BT; Heimdal K; Lubs H; Møller P; King MC
    Am J Hum Genet; 1997 Dec; 61(6):1254-60. PubMed ID: 9399897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
    Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
    Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.
    Liaw D; Marsh DJ; Li J; Dahia PL; Wang SI; Zheng Z; Bose S; Call KM; Tsou HC; Peacocke M; Eng C; Parsons R
    Nat Genet; 1997 May; 16(1):64-7. PubMed ID: 9140396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cells. PTEN--coupling tumor suppression to stem cells?
    Penninger JM; Woodgett J
    Science; 2001 Dec; 294(5549):2116-8. PubMed ID: 11739945
    [No Abstract]   [Full Text] [Related]  

  • 37. Mutations of the human PTEN gene.
    Bonneau D; Longy M
    Hum Mutat; 2000; 16(2):109-22. PubMed ID: 10923032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of PTEN, a phosphatase gene, in inherited and sporadic nonmedullary thyroid tumors.
    Eng C
    Recent Prog Horm Res; 1999; 54():441-52; discussion 453. PubMed ID: 10548886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PTEN gene and integrin signaling in cancer.
    Tamura M; Gu J; Tran H; Yamada KM
    J Natl Cancer Inst; 1999 Nov; 91(21):1820-8. PubMed ID: 10547389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Redox regulation of PI 3-kinase signalling via inactivation of PTEN.
    Leslie NR; Bennett D; Lindsay YE; Stewart H; Gray A; Downes CP
    EMBO J; 2003 Oct; 22(20):5501-10. PubMed ID: 14532122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.